Beck Mack & Oliver »

AstraZeneca shares owned by Beck Mack & Oliver

Quarter-by-quarter ownership of AstraZeneca (AZN) shares owned by Beck Mack & Oliver from 13F filings

Historical chart of Beck Mack & Oliver investment in AstraZeneca

Tip: Access up to 7 years of quarterly data

All positions including AstraZeneca held by Beck Mack & Oliver consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AstraZeneca by Beck Mack & Oliver

Quarter filed Position value Share count Share price at filing
2023-09-30 $235k 3.5k 67.72

More positions owned by Beck Mack & Oliver

Apollo Global Mgmt (APO)
Blackstone Group Inc Com Cl A (BX)
Microsoft Corporation (MSFT)
Enstar Group (ESGR)
Ashtead Group Ord Gbp0.10 Isin #gb0000536739 Sedol #0053673 (ASHTF)
Arthur J. Gallagher & Co. (AJG)
Alphabet Inc Class C cs (GOOG)
Credit Acceptance (CACC)
Laboratory Corp. of America Holdings (LH)
Charles Schwab Corporation (SCHW)
Roper Industries (ROP)
RadNet (RDNT)
Zurn Water Solutions Corp Zws (ZWS)
Abbott Laboratories (ABT)
Enterprise Products Partners (EPD)

View all positions for Beck Mack & Oliver

Top funds holding AstraZeneca

T. Rowe Price Associates
Wellington Management Company
PRIMECAP Management Company
Jennison Associates
Sanders Capital
Goldman Sachs Group
Bank of America Corporation
Franklin Resources
Fisher Investments
Holocene Advisors
Dimensional Fund Advisors
ClearBridge Advisors
Jpmorgan Chase & Co
WCM Investment Management
Wells Fargo & Company

View all funds holding AstraZeneca